A common theme when talking to pharmacists is a desire to offer new services, funded services of course, and the ability to offer publicly-funded MURs and MTAs is often brought up as an example of this.
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes